Structured evidence table for Selenium Cognitive Function Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Selenium Cognitive Function Randomized Trial | Background/Objectives: Cognitive decline in older people is greatly affected by various risk factors, especially imbalances in trace elements. | 4 | Charernwat P (2025) | Associations Between Serum Selenium, Zinc, and Copper Levels and Cognitive Function in the Elderly. |
| Selenium Cognitive Function Randomized Trial | Specifically, adequate serum selenium and zinc levels are associated with enhanced cognitive performance, while elevated copper may indicate a pro-oxidant state detrimental to cognitive function. | 4 | Charernwat P (2025) | Associations Between Serum Selenium, Zinc, and Copper Levels and Cognitive Function in the Elderly. |
| Selenium Cognitive Function Randomized Trial | Consequently, these three elements offer promise as practical, accessible biomarkers for the early identification and risk stratification of individuals susceptible to cognitive impairment. | 4 | Charernwat P (2025) | Associations Between Serum Selenium, Zinc, and Copper Levels and Cognitive Function in the Elderly. |
| Selenium Cognitive Function Randomized Trial | This study aimed to examine the relationships between serum levels of selenium, zinc, and copper and cognitive impairment. | 4 | Charernwat P (2025) | Associations Between Serum Selenium, Zinc, and Copper Levels and Cognitive Function in the Elderly. |
Source documents